obp Medical Corporation

Canaccord Genuity acts as Financial Advisor to obp Medical Corporation on the sale of its Non-Surgical Business to CooperSurgical, Inc

Canaccord Genuity is pleased to announce that on May 3, 2021, obp Medical Corporation (“obp,” or the “Company”), a privately-held medical technology company pioneering novel single-use medical devices that feature integrated advanced LED illumination, completed the sale of its Non-Surgical Business to CooperSurgical, Inc., a subsidiary of The Cooper Companies, Inc. for $60 million in cash consideration.

Canaccord Genuity is acting as financial advisor to obp and its Board of Directors in connection with the transaction.

obp’s Non-Surgical Business consists of a suite of differentiated single-use medical devices that maximize clinical efficiency and functionality for healthcare providers while simultaneously improving comfort and overall outcomes for patients. The Company’s devices feature integrated advanced LED illumination and are self-contained, arriving ready for use with no additional components, assembly or reprocessing required; enabling mitigation of cross-contamination risk while using technology that is simple and cost-effective.

CooperSurgical, Inc. is a leader in manufacturing and marketing a wide range of trusted, innovative brands and impactful solutions that have assisted clinicians in advancing the standard of healthcare for women and families worldwide. CooperSurgical, Inc. is a wholly-owned subsidiary of The Cooper Companies, Inc.